STALing B cell responses with CD22

被引：3
|
作者：
Chappell, Craig P. [1 ]
Clark, Edward A. [1 ]
机构：
[1] Univ Washington, Dept Immunol, Seattle, WA 98195 USA
来源：
JOURNAL OF CLINICAL INVESTIGATION | 2013年 / 123卷 / 07期
关键词：
PLASMACYTOID DENDRITIC CELLS; ANTIGEN DELIVERY; FACTOR-VIII; T-CELL; ENHANCEMENT; SIGNALS;
D O I：
10.1172/JCI69670
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Suppressing unwanted humoral immune responses without compromising the host's ability to respond to foreign pathogens is a primary goal for therapies aimed at ameliorating harmful autoantibody production. Global suppression of the immune system via lymphocyte depletion and/or immunosuppressive drugs can have off-target effects, a limitation to conventional therapies. In this issue of the JCI, Macauley and colleagues utilize a novel platform to inhibit antigen-specific antibody production that preserves the immune system's ability to respond to unrelated antigens.
引用
收藏
页码：2778 / 2780
页数：3
相关论文
共 50 条
  • [21] Expression and function of CD22, a B-cell restricted molecule
    Moyron-Quiroz, JE
    Partida-Sánchez, S
    Donís-Hernández, R
    Sandoval-Montes, C
    Santos-Argumedo, L
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2002, 55 (04) : 343 - 351
  • [22] CD22 is a negative regulator of B-cell receptor signalling
    Nitschke, L
    Carsetti, R
    Ocker, B
    Kohler, G
    Lamers, MC
    CURRENT BIOLOGY, 1997, 7 (02) : 133 - 143
  • [23] Epratuzumab: Targeting B-cell malignancies through CD22
    Coleman, M
    Goldenberg, DM
    Siegel, AB
    Ketas, JC
    Ashe, M
    Fiore, JM
    Leonard, JP
    CLINICAL CANCER RESEARCH, 2003, 9 (10) : 3991S - 3994S
  • [24] REGULATION OF CD45 ENGAGEMENT BY THE B-CELL RECEPTOR CD22
    SGROI, D
    KORETZKY, GA
    STAMENKOVIC, I
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) : 4026 - 4030
  • [25] Regulation of Human CD27+IgM+B Cell Activation by Cis-Binding of the Inhibitory Molecule CD22 to CD22 Ligand (CD22L)
    Dijke, Esme
    Derkatz, Kim
    Pearcey, Jean
    Wong, Fred
    Motyka, Bruce
    West, Lori
    TRANSPLANTATION, 2017, 101 (05) : S5 - S5
  • [26] Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact
    Collins, BE
    Blixt, O
    DeSieno, AR
    Bovin, N
    Marth, JD
    Paulson, JC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (16) : 6104 - 6109
  • [27] Dendritic cell-dependent inhibition of B cell proliferation requires CD22
    Santos, Lorna
    Draves, Kevin E.
    Boton, Mark
    Grewal, Prabhjit K.
    Marth, Jamey D.
    Clark, Edward A.
    JOURNAL OF IMMUNOLOGY, 2008, 180 (07): : 4561 - 4569
  • [28] Exploiting the inhibitory function of CD22 on B-cells to prevent antibody responses
    Macauley, Matthew
    Arlian, Britni
    Bednar, Kyle
    Duan, Shiteng
    Fung-Leung, Wai-Ping
    Kulis, Mike
    Hardy, Lakeya
    Nycholat, Corwin
    Orgel, Kelly
    Pang, Lijuan
    Paulson, James
    Rao, Tadimeti
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [29] Analysis of tyrosine phosphorylation sites of CD22 upon B cell activation
    Fujimoto, M
    Yoshitake, S
    Tedder, TF
    Takehara, K
    FASEB JOURNAL, 2005, 19 (04): : A953 - A953
  • [30] Insights into the transcriptional regulation of CD22 in B cell chronic lymphocytic leukemia
    Enkhbayar, Bayarmaa
    Lu, Shao-Chia
    Tsai, Ho-Yang
    Liang, Suh-Yuen
    Wu, Shang-Ju
    Lin, Kuo-, I
    Angata, Takashi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2025, 301 (04)
12345